NO116552B - - Google Patents
Download PDFInfo
- Publication number
- NO116552B NO116552B NO153864A NO15386464A NO116552B NO 116552 B NO116552 B NO 116552B NO 153864 A NO153864 A NO 153864A NO 15386464 A NO15386464 A NO 15386464A NO 116552 B NO116552 B NO 116552B
- Authority
- NO
- Norway
- Prior art keywords
- pantothenic acid
- streptomycin
- salt
- sulfate
- components
- Prior art date
Links
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 65
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 36
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 33
- 229940055726 pantothenic acid Drugs 0.000 claims description 33
- 235000019161 pantothenic acid Nutrition 0.000 claims description 33
- 239000011713 pantothenic acid Substances 0.000 claims description 33
- 150000003839 salts Chemical class 0.000 claims description 22
- 229960005322 streptomycin Drugs 0.000 claims description 18
- 230000003115 biocidal effect Effects 0.000 claims description 13
- 239000003242 anti bacterial agent Substances 0.000 claims description 11
- 229940088710 antibiotic agent Drugs 0.000 claims description 10
- 241000187747 Streptomyces Species 0.000 claims description 8
- 229930193140 Neomycin Natural products 0.000 claims description 7
- 229960004927 neomycin Drugs 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 6
- 150000002948 pantothenic acids Chemical class 0.000 claims description 6
- GXFAIFRPOKBQRV-GHXCTMGLSA-N viomycin Chemical compound N1C(=O)\C(=C\NC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)C[C@@H](N)CCCN)CNC(=O)[C@@H]1[C@@H]1NC(=N)N[C@@H](O)C1 GXFAIFRPOKBQRV-GHXCTMGLSA-N 0.000 claims description 6
- 229950001272 viomycin Drugs 0.000 claims description 6
- OZKXLOZHHUHGNV-UHFFFAOYSA-N Viomycin Natural products NCCCC(N)CC(=O)NC1CNC(=O)C(=CNC(=O)N)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(NC1=O)C2CC(O)NC(=N)N2 OZKXLOZHHUHGNV-UHFFFAOYSA-N 0.000 claims description 5
- 108010015940 Viomycin Proteins 0.000 claims description 5
- 238000001784 detoxification Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 230000036571 hydration Effects 0.000 claims 1
- 238000006703 hydration reaction Methods 0.000 claims 1
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 10
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 10
- 229960002385 streptomycin sulfate Drugs 0.000 description 10
- 229960002079 calcium pantothenate Drugs 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 239000002585 base Substances 0.000 description 8
- CZWJCQXZZJHHRH-YCRXJPFRSA-N 2-[(1r,2r,3s,4r,5r,6s)-3-(diaminomethylideneamino)-4-[(2r,3r,4r,5s)-3-[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;sulfuric acid Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O CZWJCQXZZJHHRH-YCRXJPFRSA-N 0.000 description 7
- ASXBYYWOLISCLQ-UHFFFAOYSA-N Dihydrostreptomycin Natural products O1C(CO)C(O)C(O)C(NC)C1OC1C(CO)(O)C(C)OC1OC1C(N=C(N)N)C(O)C(N=C(N)N)C(O)C1O ASXBYYWOLISCLQ-UHFFFAOYSA-N 0.000 description 7
- 238000007792 addition Methods 0.000 description 7
- 229960002222 dihydrostreptomycin Drugs 0.000 description 7
- ASXBYYWOLISCLQ-HZYVHMACSA-N dihydrostreptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O ASXBYYWOLISCLQ-HZYVHMACSA-N 0.000 description 7
- 229960001162 dihydrostreptomycin sulfate Drugs 0.000 description 7
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 6
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 241000282414 Homo sapiens Species 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 231100000636 lethal dose Toxicity 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 159000000007 calcium salts Chemical class 0.000 description 3
- 235000011132 calcium sulphate Nutrition 0.000 description 3
- 239000001175 calcium sulphate Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 231100000563 toxic property Toxicity 0.000 description 3
- GHSCYMOJHVOGDJ-UHFFFAOYSA-N 2-(diethylamino)ethyl 4-amino-2-hydroxybenzoate Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1O GHSCYMOJHVOGDJ-UHFFFAOYSA-N 0.000 description 2
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 description 2
- AWBXTNNIECFIHT-XZQQZIICSA-N 2-[(1r,2r,3s,4r,5r,6s)-3-(diaminomethylideneamino)-4-[(2r,3r,4r,5s)-3-[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;2-[(1r,2r,3s,4r,5r,6s)-3-( Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O AWBXTNNIECFIHT-XZQQZIICSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- -1 pantothenal Chemical class 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- VQGRPWQSNMEBHD-YQQOEYNUSA-N (3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4S,6R)-2-amino-4-hydroxy-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide 3-[[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoic acid sulfuric acid Chemical compound OS(O)(=O)=O.OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O.N1C(=O)\C(=C\NC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)C[C@@H](N)CCCN)CNC(=O)[C@@H]1[C@@H]1NC(N)=N[C@@H](O)C1 VQGRPWQSNMEBHD-YQQOEYNUSA-N 0.000 description 1
- YXIORFGPXSLCOT-FGZKHVCBSA-N 2-[(1r,2r,3s,4r,5r,6s)-3-(diaminomethylideneamino)-4-[(2r,3r,4r,5s)-3-[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;3-[[(2r)-2,4-dihydroxy-3,3 Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O.O1[C@@H](CO)[C@H](O)[C@@H](O)[C@H](NC)[C@@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O YXIORFGPXSLCOT-FGZKHVCBSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 239000004107 Penicillin G sodium Substances 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 241000187438 Streptomyces fradiae Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 235000019369 penicillin G sodium Nutrition 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- GQTHJBOWLPZUOI-FJXQXJEOSA-M sodium D-pantothenate Chemical compound [Na+].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O GQTHJBOWLPZUOI-FJXQXJEOSA-M 0.000 description 1
- 229940068459 sodium pantothenate Drugs 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B61—RAILWAYS
- B61G—COUPLINGS; DRAUGHT AND BUFFING APPLIANCES
- B61G9/00—Draw-gear
- B61G9/04—Draw-gear combined with buffing appliances
- B61G9/06—Draw-gear combined with buffing appliances with rubber springs
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B61—RAILWAYS
- B61G—COUPLINGS; DRAUGHT AND BUFFING APPLIANCES
- B61G9/00—Draw-gear
- B61G9/04—Draw-gear combined with buffing appliances
- B61G9/10—Draw-gear combined with buffing appliances with separate mechanical friction shock-absorbers
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Gears, Cams (AREA)
- Basic Packing Technique (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Vibration Dampers (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US296643A US3227288A (en) | 1963-07-22 | 1963-07-22 | Draft gear |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO116552B true NO116552B (is) | 1969-04-14 |
Family
ID=23142902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO153864A NO116552B (is) | 1963-07-22 | 1964-06-30 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3227288A (is) |
| AT (1) | AT275597B (is) |
| BE (1) | BE650857A (is) |
| CH (1) | CH425355A (is) |
| DE (1) | DE1455238A1 (is) |
| ES (1) | ES302276A1 (is) |
| GB (1) | GB1037509A (is) |
| LU (1) | LU46548A1 (is) |
| NL (2) | NL6408371A (is) |
| NO (1) | NO116552B (is) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3376031A (en) * | 1965-10-19 | 1968-04-02 | Destech Labs Inc | Shock absorber |
| US3465900A (en) * | 1966-08-30 | 1969-09-09 | Symington Wayne Corp | Friction-polyurethane rubber draft gear |
| US3485385A (en) * | 1966-10-03 | 1969-12-23 | Keystone Ind Inc | Impact absorbing apparatus |
| US3491898A (en) * | 1967-09-13 | 1970-01-27 | Dresser Ind | Housed draft gear |
| US3708075A (en) * | 1971-08-05 | 1973-01-02 | Miner Enterprises | Wedge lock device |
| US4074813A (en) * | 1976-10-15 | 1978-02-21 | Miner Enterprises, Inc. | Telescopic draft gear |
| US4198037A (en) * | 1976-12-28 | 1980-04-15 | Miner Enterprises, Inc. | Method of making polyester elastomer compression spring and resulting product |
| DE2918092A1 (de) * | 1979-05-04 | 1980-11-13 | Ringfeder Gmbh | Vorrichtung zur federnden aufnahme von kraeften, insbesondere fuer eine mittelpufferkupplung von schienenfahrzeugen |
| US5065874A (en) * | 1990-10-22 | 1991-11-19 | Miner Enterprises, Inc. | Preshortening insert for a draft gear |
| US5351844A (en) * | 1993-06-01 | 1994-10-04 | Miner Enterprises, Inc. | Elastomeric spring unit |
| US6360906B1 (en) | 2000-07-21 | 2002-03-26 | Amsted Industries Incorporated | Slackless railway coupler with buff/draft gear |
| ZA201506345B (en) * | 2014-09-29 | 2017-03-29 | Amsted Rail Co Inc | Railroad car draft gear |
| CN112985707B (zh) * | 2019-12-16 | 2023-03-21 | 中车唐山机车车辆有限公司 | 一种自动车钩及缓冲装置气密性试验方法 |
| RU199443U1 (ru) * | 2019-12-19 | 2020-09-01 | Общество с ограниченной ответственностью "Алтайский сталелитейный завод" | Конус нажимной поглощающего аппарата |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA540674A (en) * | 1957-05-07 | A. Andrews Joseph | Draft gear | |
| US2118150A (en) * | 1935-07-02 | 1938-05-24 | E Lee Trinkle Jr | Draft rigging |
| US2160417A (en) * | 1936-06-24 | 1939-05-30 | American Steel Foundries | Draft-gear housing |
| US2670856A (en) * | 1948-05-19 | 1954-03-02 | American Steel Foundries | Draft gear |
| US2623743A (en) * | 1950-05-01 | 1952-12-30 | Miner Inc W H | Friction shock absorber for railway car trucks |
| US2808945A (en) * | 1953-11-05 | 1957-10-08 | Miner Inc W H | Shock absorbing mechanisms |
| US2764300A (en) * | 1954-03-25 | 1956-09-25 | Miner Inc W H | Friction shock absorbing mechanisms for railway draft riggings |
| AT196441B (de) * | 1956-01-21 | 1958-03-25 | Bergische Stahl Ind Kommandit | Elastische Kupplungsstangenanlenkung für Fahrzeuge |
| US2903143A (en) * | 1956-11-23 | 1959-09-08 | Miner Inc W H | Shock absorbing mechanism |
| US2906415A (en) * | 1956-12-28 | 1959-09-29 | American Steel Foundries | Draft gear |
| DE1154311B (de) * | 1960-06-23 | 1963-09-12 | Lemfoerder Metallwarengesellsc | Hohlfeder aus Gummi oder gummielastischem Kunststoff |
-
0
- NL NL134080D patent/NL134080C/xx active
-
1963
- 1963-07-22 US US296643A patent/US3227288A/en not_active Expired - Lifetime
-
1964
- 1964-06-30 NO NO153864A patent/NO116552B/no unknown
- 1964-06-30 GB GB26938/64A patent/GB1037509A/en not_active Expired
- 1964-07-16 LU LU46548D patent/LU46548A1/xx unknown
- 1964-07-21 AT AT626264A patent/AT275597B/de active
- 1964-07-21 ES ES0302276A patent/ES302276A1/es not_active Expired
- 1964-07-21 DE DE19641455238 patent/DE1455238A1/de not_active Withdrawn
- 1964-07-22 BE BE650857A patent/BE650857A/xx unknown
- 1964-07-22 NL NL6408371A patent/NL6408371A/xx unknown
- 1964-07-22 CH CH956464A patent/CH425355A/de unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE650857A (is) | 1965-01-22 |
| LU46548A1 (is) | 1964-09-16 |
| US3227288A (en) | 1966-01-04 |
| NL6408371A (is) | 1965-01-25 |
| AT275597B (de) | 1969-10-27 |
| CH425355A (de) | 1966-11-30 |
| DE1455238A1 (de) | 1969-04-30 |
| NL134080C (is) | |
| ES302276A1 (es) | 1965-10-16 |
| GB1037509A (en) | 1966-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO116552B (is) | ||
| SU1410866A3 (ru) | Способ получени стеарата ацетилэритромицина | |
| NO164419B (no) | Vannopploeselig celluloseeter og en fremgangsmaate for fremstilling derav. | |
| US2950309A (en) | Amphetamine tannate | |
| US3997559A (en) | N-acetyl-L-hydroxy-proline zinc salt | |
| US2891943A (en) | Novel antibiotically active products | |
| US3144445A (en) | Crystalline form of d-6-(2-amino-2-phenyl-acetamido) penicillanic acid | |
| DE2721987C2 (de) | p-Acetamidophenyldiäthylaminoacetat, dessen pharmakologisch unbedenkliche Additionssalze, Verfahren zu deren Herstellung und Arzneimittel mit diesen Verbindungen als Wirkstoff | |
| CH621334A5 (is) | ||
| US3000874A (en) | Sulfate salt of erythromycin monoester | |
| DE1006417B (de) | Verfahren zur Herstellung von O, O-Dialkyl-thiolthiono-phosphorsaeure-S-aralkylmercaptoalkylestern | |
| US3179562A (en) | Treatment of diabetes with alpha, alpha substituted acetic acid derivatives | |
| JPS60132999A (ja) | エリスロマイシンのチオ−ル誘導体、その製造方法並びにそれを含有する組成物 | |
| JPS6163695A (ja) | プリマイシン塩、その製造法および医薬組成物 | |
| US2885321A (en) | Treating poultry respiratory infections with erythromycin | |
| DE1965343A1 (de) | Arzneimittel,insbesondere zur Herabsetzung der Schleimviskositaet und Anwendung als hustenstillendes Mittel,und Verfahren zu seiner Herstellung | |
| US3809760A (en) | Calcium salt of n-acetyl-6-amino-hexanoic acid and medicaments containing this salt | |
| US3700770A (en) | Phenylalanine derivatives for treatment of measles infections | |
| US2967129A (en) | New erythromycin esters | |
| DE2407016B2 (de) | 2-Alkoxybenzoylaminocarbonsäuren, Verfahren zu deren Herstellung und diese Verbindungen enthaltende antipyretische Mittel | |
| DE2408372A1 (de) | Pharmazeutische zubereitungen auf der grundlage von hippursaeurederivaten | |
| US3078300A (en) | Processes of production of new compositions and derivatives of chloramphenicols withreduced toxicity and products thereof | |
| JPS6075431A (ja) | エリスロマイシンの塩およびそれを有効成分とする抗生−免疫賦活剤 | |
| US2478984A (en) | Medicinal preparation containing available calcium and phosphorus | |
| US2378889A (en) | 3,4-dihydroxyphenisopropyl alkylamines |